Close Menu

NEW YORK (GenomeWeb) — Centogene said today that it has launched a two-year study to investigate the genetic factors involved in Parkinson's disease in collaboration with the University of Lübeck in Germany.

The study — called the Rostock International Parkinson's Disease Study, or ROPAD — will enroll around 10,000 individuals worldwide and use Centogene's CentoCard dried blood spot collection kit to identify study participants with mutations in Parkinson's disease-associated genes including LRRK2 and GBA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.